0 items USD 0.00Search
Your search for "mrrpb5 global acute repetitive seizures drugs market size status forecast 2019 2025" gave back 1549437 results.
KI happens in people who are already sick and in the hospital. People who are in the intensive care unit (ICU) are even more likely than people who...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Acute Ischemic Stroke Diagnosis and Treatment market was valued at US$ 1049.8 million in 2023 and is anticipated to reach US$ 1325.2...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Severe Acute Respiratory Syndrome (SARS) Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Organophosphate and Carbamate Poisoning Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global...
Catalog:
Global Markets Direct
August 2022
Price: USD 2,000.00
Organophosphate and Carbamate Poisoning (Other Diseases) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
August 2021
Price: USD 2,000.00
Organophosphate and Carbamate Poisoning - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
October 2020
Price: USD 2,000.00
Organophosphate and Carbamate Poisoning - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
April 2020
Price: USD 2,000.00
The global Drugs For Sinusitis market size was valued at USD 2300.7 million in 2023 and is forecast to a readjusted size of USD 2916.3 million by...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Organophosphate and Carbamate Poisoning - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
October 2018
Price: USD 2,000.00
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Epilepsy is associated with disrupted activities in the brain called seizures, which affects the central nervous system. Depending on the area of the...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Levetiracetam is a drug used to treat epilepsy. It is used for partial seizures, myoclonus or tonic - clonic seizures. The global Levetiracetam...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
According to market experts acute skin and skin structure infections (ABSSSI) comprise set of bacterial infections that involve multiple layers of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
